Answer
No. Alymsys is an intravenous oncology formulation and is not formulated or authorised for eye injection. Any off-label ophthalmic use of bevacizumab is a separate specialist decision.
Sources for this answer
- Alymsys 25 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.